Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Alector Inc (ALEC)

13.29   0.06 (0.45%) 11-27 00:41
Open: 13.23 Pre. Close: 13.23
High: 13.49 Low: 13.16
Volume: 367,355 Market Cap: 1,053M
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in phase II clinical trial for the treatment of frontotemporal dementia disease; and AL101 that is in Phase I clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. The company also offers AL002 and AL003, which are in phase 1b clinical trial for the treatment of Alzheimer's disease. In addition, it has 10 programs under research and development stage. The company has a collaboration agreement with Adimab, LLC for the research and development of antibodies. Alector, Inc. was founded in 2013 and is headquartered in South San Francisco, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 13.498 - 13.538 13.538 - 13.583
Low: 13.039 - 13.087 13.087 - 13.142
Close: 13.204 - 13.278 13.278 - 13.36

Technical analysis

as of: 2020-11-25 4:35:23 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 15.76     One year: 18.40
Support: Support1: 10.79    Support2: 9.12
Resistance: Resistance1: 13.49    Resistance2: 15.76
Pivot: 12.48
Moving Average: MA(5): 12.91     MA(20): 11.86
MA(100): 13.78     MA(250): 20.78
MACD: MACD(12,26): 0.64     Signal(9): 0.50
Stochastic oscillator: %K(14,3): 91.92     %D(3): 87.16
RSI: RSI(14): 66.22
52-week: High: 35.93  Low: 9.12  Change(%): -28.7
Average Vol(K): 3-Month: 89074  10-Days: 60326

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
ALEC has closed below upper band by 15.4%. Bollinger Bands are 50.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to ALEC's normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 26 Nov 2020
Alector, Inc. (NASDAQ:ALEC) has failed to excite in 2020, the stock is down ~-22.87% year-to-date - Marketing Sentinel

Sat, 21 Nov 2020
Here is a bargain stock you should look at : Alector, Inc. (ALEC) - Marketing Sentinel

Thu, 12 Nov 2020
Alector, Inc. (NASDAQ:ALEC) Just Released Its Third-Quarter Earnings: Here's What Analysts Think - Nasdaq

Tue, 10 Nov 2020
Alector: 3Q Earnings Snapshot - Houston Chronicle

Tue, 10 Nov 2020
Alector Reports Third Quarter 2020 Financial Results and Provides Corporate Update - GlobeNewswire

Thu, 05 Nov 2020
Alector, Inc. (NASDAQ:ALEC) 19.51% Above its 52-week Low, How Long Will it Keep Rising? - Marketing Sentinel

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 79
Shares Float (M) 52
% Held by Insiders 17.29
% Held by Institutions 78.77
Shares Short (K) 10,430
Shares Short P. Month (K) 10,670

Stock Financials

EPS -2.250
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 3.910
Profit Margin
Operating Margin -780.36
Return on Assets (ttm) -22.1
Return on Equity (ttm) -63.8
Qtrly Rev. Growth 119.0
Gross Profit (p.s.) -1.001
Sales Per Share 0.281
EBITDA (p.s.) -2.118
Qtrly Earnings Growth
Operating Cash Flow (M) -148
Levered Free Cash Flow (M) -73

Stock Valuations

PE Ratio -5.91
PEG Ratio
Price to Book value 3.40
Price to Sales 47.33
Price to Cash Flow -7.12

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.